- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 9.43M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $990.56M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $971.28M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $118.25M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $77.48M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $396.26M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $374.48M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.71B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.67B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.12B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.23B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.13B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 9.56M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $23.99M |
| Capex | Q1 2025 · Mar 31, 2024 | $13.56M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $102.84M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.15B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.08B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $11.23 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $11.23 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $44.37M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $31.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | $107.73M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $140.8M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $216.37M |
| Revenue | Q1 2025 · Mar 31, 2024 | $696.74M |